Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 27
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Automatic Adaptation of Basal Insulin using Sensor-augmented Pump Therapy

  • Herrero, Pau
  • Giménez, M.
  • Oliver, Nick
  • Georgiou, Pantelis
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: People with insulin-dependent diabetes rely on an intensified insulin regimen. Despite several guidelines, they are usually impractical and fall short in achieving optimal glycemic outcomes. In this work, a novel technique for automatic adaptation of the basal insulin profile of people with diabetes on sensor-augmented pump therapy is presented. Methods: The presented technique is based on a run-to-run control law that overcomes some of the limitations of previously proposed methods. To prove its validity, an in silico validation was performed. Finally, the artificial intelligence technique of case-based reasoning is proposed as a potential solution to deal with variability in basal insulin requirements. Results: Over a period of 4 months, the proposed run-to-run control law successfully adapts the basal insulin profile of a virtual population (10 adults, 10 adolescents, and 10 children). In particular, average percentage time in target [70, 180] mg/dl was significantly improved over the evaluated period (first week versus last week): 70.9 ± 11.8 versus 91.1 ± 4.4 (adults), 46.5 ± 11.9 versus 80.1 ± 10.9 (adolescents), 49.4 ± 12.9 versus 73.7 ± 4.1 (children). Average percentage time in hypoglycemia (<70 mg/dl) was also significantly reduced: 9.7 ± 6.6 versus 0.9 ± 1.2 (adults), 10.5 ± 8.3 versus 0.83 ± 1.0 (adolescents), 10.9 ± 6.1 versus 3.2 ± 3.5 (children). When compared against an existing technique over the whole evaluated period, the presented approach achieved superior results on percentage of time in hypoglycemia: 3.9 ± 2.6 versus 2.6 ± 2.2 (adults), 2.9 ± 1.9 versus 2.0 ± 1.5 (adolescents), 4.6 ± 2.8 versus 3.5 ± 2.0 (children), without increasing the percentage time in hyperglycemia. Conclusion: The present study shows the potential of a novel technique to effectively adjust the basal insulin profile of a type 1 diabetes population on sensor-augmented insulin pump therapy., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has received funding from the European Union s Horizon 2020 research and innovation program under grant agreement 689810.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Case-base maintenance of a personalised and adaptive CBR bolus insulin recommender system for type 1 diabetes

  • Torrent-Fontbona, Ferran
  • Massana i Raurich, Joaquim
  • López Ibáñez, Beatriz
People with type 1 diabetes must control their blood glucose level through insulin infusion either with several daily injections or with an insulin pump. However, estimating the required insulin dose is not easy. Recommender systems, mainly based on Case-Based Reasoning (CBR), are being developed to provide recommendations to users. These systems are designed to keep the experiences or cases of the user in a case-base, which requires maintenance to keep system's response accurate and efficient. This paper proposes a case-base maintenance methodology that combines case-base redundancy reduction and attribute weight learning. Contrary to previous approaches designed for classification problems, the maintenance methodology presented in this paper deals with numerical recommendations. It can manage a potentially huge case-base due to the combinatorial derived from the number of attributes used to represent a case. The proposed approach has been tested using the UVA/PADOVA type 1 diabetes simulator and the results demonstrate that it can accomplish better levels of accuracy than other insulin recommender systems mentioned in the literature, when a large number of attributes is considered, This project has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement No. 689810, www.pepper.eu.com/, PEPPER, and the grant of the University of Girona 20162018 (MPCUdG2016). The work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 20142016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Avaluació d'un sistema personalitzat de suport de decisions d'autogestion de la DM1 [Pòster]

  • Wos, Marzena
  • Leal Moncada, Yenny Teresa
  • Fernández-Balsells, Mercè
  • Martin, Clare
  • Herrero i Viñas, Pau
  • López Ibáñez, Beatriz
  • Ricart, Wilfredo
  • Sojo-Vega, Lidia
  • Lafuente, Esteve
  • Loshuertos, Emilio
  • Shapley, Julian
  • Nita, Lucian
  • Fernández-Real Lemos, José Manuel
Pòster de congrés presentat a: Congrés de l' Associació Catalana de Diabetis (ACD), (14è: 16-17 Març 2017: Badalona), Patient Empowerment Through Predictive Personalised Decision Support (PEPPER) és un projecte d'investigació que desenvolupa un sistema personalitzat de suport de decisions per a l'autogestió de la diabetis tipus 1 (DM1). PEPPER proporciona recomanacions pel que fa a la dosi de bolus d'insulina (utilitzant el raonament basat en casos (CBR), una tècnica d'intel·ligència artificial que s'adapta a noves situacions d'acord amb les experiències passades) i ingesta de carbohidrats, basant-se en un model informàtic predictiu que promou la seguretat, proporcionant a més, alarmes de predicció de glucèmia, suspensió d'infusió d'insulina i detecció de fallades. L'objectiu d'aquest projecte és avaluar la factibilitat, la seguretat, la usabilitat i la viabilitat del sistema PEPPER, Aquest projecte ha rebut finançament del programa de recerca i innovació Horizonte 2020 de la UE sota l’acord de subvenció nº 689810.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Cloud Based Acquisition System for Diabetic Data

  • Nita, Lucian
  • Torrent-Fontbona, Ferran
IMEKO TC4 (22è : 2017 : Iasi, Romania). 22nd IMEKO TC4 Symposium and 20th International Workshop on ADC Modelling and Testing: supporting worl development through electrical & electronic mesuraments: September 14-15, 2017, Iasi, Romania, Comunicació de congrés presentada a: IMEKO TC4 Symposium (22nd: 14-15 setembre 2017: Iasi, Romania) and International Workshop on ADC Modelling and Testing (20th: 14-15 setembre 2017: Iasi, Romania), The paper presents a system which collects medical data from people with type 1 diabetes mellitus, stores the data into a cloud database and implements web pages for data analysis. This system architecture gives possibility to clinicians and patients to share information about patient evolution without the need for the patient to physically visit the hospital. The system includes a clinical decision support system which helps the patient on insulin doses calibration, This material is based upon the work which is supported by the European Union through the H2020 “PEPPER” project: Patient Empowerment through Predictive Personalized decision support, http://www.pepper.eu.com
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A CBR-based bolus recommender system for type 1 diabetes

  • Torrent-Fontbona, Ferran
  • López Ibáñez, Beatriz
  • Pozo-Alonso, Alejandro
Comunicació de congrés presentada a: Workshop on Artificial Intelligence for Diabetes (2nd: 2017: Viena, Àustria) i Conference on Artificial Intelligence in Medicine (AIME) (16th: 2017: Viena, Àustria), Aquest workshop ha rebut finançament del programa d'investigació i innovació EU Horizon 2020 sota el núm. d'ajut 689810, People with type 1 diabetes mellitus usually need to administer bolus insulin before each meal to keep the blood glucose level in the target glycaemic range. However, the factors involved in the calculation of the appropriate dose can change due to multiple factors and with an unknown relation. This may increase the error in the bolus calculation, and therefore, increase the chances of hypoglycaemia and hyperglycaemia. This paper proposes a bolus recommender system based on case based reasoning developed under project PEPPER, with the objective of recommending personalised and adaptive bolus doses. The system has been tested with in silico adults with UVA/PADOVA T1DM simulator. Results show that the use of the proposed bolus recommender system increases the percentage of time in the target glycaemic range, This project has received funding from the grant of the University of Girona 2016-2018 (MPCUdG2016) and the European Union Horizon 2020 research and innovation programme under grant agreement No. 689810, www.pepper.eu.com/, PEPPER. The work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 2014-2016).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Adaptive basal insulin recommender system based on Kalman filter for type 1 diabetes

  • Torrent-Fontbona, Ferran
Type 1 diabetes mellitus is a chronic disease that requires those affected to self-administer insulin to control their blood glucose level. However, the estimation of the correct insulin dosage is not easy due to the complexity of glucose metabolism, which usually leads to blood glucose levels far from the optimal. This paper presents an adaptive and personalised basal insulin recommender system based on Kalman filter theory that can be used with or without continuous glucose monitoring systems. The proposed approach is tested with the UVa/PADOVA simulator with eleven virtual adult subjects. It has been tested in combination with two different bolus calculators, and the performance achieved has been compared with that obtained with the default basal doses of the simulator, which can be assumed as optimal. The achieved results demonstrate that the proposed system rapidly converges to the optimal basal dose, and it can be used with adaptive bolus calculators without the risk of instability, This project has received funding from the grant of the University of Girona 2016-2018 (MPCUdG2016) and the European Union Horizon 2020 research and innovation programme under grant agreement No. 689810, www.pepper.eu.com/, PEPPER
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

A novel, adaptive decision support system for diabetes self-management using artificial intelligence and mathematical modelling [Pòster]

  • PEPPER (Patient Empowerment through Predictive PERsonalised decision support)
  • Oxford Brookes University
  • Imperial college London
  • Universitat de Girona
  • Institut d’Investigació Biomèdica de Girona (IdIBGi)
Pòster de congrés presentat a: ICT 2018: Imagine Digital - Connect Europe (4-6 Desembre: Viena, Austria), PEPPER (Patient Empowerment through Predictive PERsonalised decision support) is a research and innovation project to develop a personalised clinical decision support system for Type 1 diabetes self-management. The tool provides insulin bolus dose advice and carbohydrate recommendations, tailored to the needs of individuals. The former is determined by Case-Based Reasoning (CBR, Fig. 1), an artificial intelligence technique that adapts to new situations according to past experience. The latter uses a model-based approach (Fig. 2) that also promotes safety by providing glucose alarms, low-glucose insulin suspension and fault detection, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Personalised Clinical Decision Support For Diabetes Management Using Real-time Data [Pòster]

  • Martin, Clare
  • Aldea, Arantza
  • Brown, Daniel
  • Duce, David
  • Fernández-Real Lemos, José Manuel
  • Gay Sacristán, Pablo
  • Georgiou, Pantelis
  • Harrison, R.
  • Herrero i Viñas, Pau
  • Innocenti, Bianca
  • López Ibáñez, Beatriz
  • Leal Moncada, Yenny Teresa
  • Nita, Lucian
  • Pesl, Peter
  • Petite, Roberto
  • Reddy, Monika
  • Shapley, Julian
  • Torrent-Fontbona, Ferran
  • Waite, Marion
  • Wos, Marzena
  • Oliver, Nick
Pòster de congrés presentat a: International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (10th: 15-18 Febrer 2017: Berlin), PEPPER (Patient Empowerment through Predictive PERsonalised decision support) is an EU-funded research project to develop a personalised clinical decision support system for Type 1 diabetes self-management. The tool provides insulin bolus dose advice and carbohydrate recommendations, tailored to the needs of individuals. The former is determined by Case-Based Reasoning (CBR), an artificial intelligence technique that adapts to new situations according to past experience. The latter uses a predictive computer model that also promotes safety by providing glucose alarms, low-glucose insulin suspension and fault detection, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Negative results for the prediction of postprandial hypoglycemias from insulin intakes and carbohydrates: analysis and comparison with simulated data

  • Dubosson, Fabien
  • Mordvanyuk, Natalia
  • López Ibáñez, Beatriz
  • Schumacher, Michael
Comunicació de congrés presentada a: Workshop on Artificial Intelligence for Diabetes (2nd: 2017: Viena, Àustria). Aquest workshop ha rebut finançament del programa d'investigació i innovació EU Horizon 2020 sota el núm. d'ajut 689810, Diabetic patients usually take insulin bolus right before eating a meal. A wrong dosage of insulin may lead to a hypoglycemia. Being able to anticipate such insulin-induced, postprandial hypoglycemias would enable warning of the patients about the risk associated with the quantity of insulin they are planning to take. In this work, we explore the feasibility of predicting these postprandial hypoglycemias by using information available at pre-meal time, such as glucose levels, planned insulin intakes and carbohydrates estimations. First, an experiment has been done on a dataset acquired on real patients, for which several classes of machine learning algorithms have been tried. The obtained results do not offer predictions that are useful enough to consider any usage in real-life applications. These kinds of datasets - acquired on real patients - suffer heavily from missing data and incorrect carbohydrates estimations though. In order to analyse the impact of these flaws on the obtained results, the same experiment has been run on a simulated dataset. Results support that even with the simulated dataset, which does not have missing data and which has precise carbohydrates intake, these features alone are not able to predict postprandial hypoglycemia. Therefore, improving the quality of patients annotations is not enough to solve the problem, and using these features without further features engineering does not offer good results
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A modular safety system for an insulin dose recommender: a feasibility study

  • Liu, Chengyuan
  • Avari, Parizad
  • Leal Moncada, Yenny Teresa
  • Wos, Marzena
  • Sivasithamparam, Kumuthine
  • Pantelis, Georgiou
  • Reddy, Monika
  • Fernández-Real Lemos, José Manuel
  • Martin, Clare
  • Fernández-Balsells, Mercè
  • Oliver, Nick
  • Herrero i Viñas, Pau
Delivering insulin in type 1 diabetes is a challenging, and potentially risky, activity; hence the importance of including safety measures as part of any insulin dosing or recommender system. This work presents and clinically evaluates a modular safety system that is part of an intelligent insulin dose recommender platform developed within the EU-funded PEPPER project. METHODS: The proposed safety system is composed of four modules which use a novel glucose forecasting algorithm. These modules are predictive glucose alerts and alarms; a predictive low-glucose basal insulin suspension module; an advanced rescue carbohydrate recommender for resolving hypoglycemia; and a personalized safety constraint applied to insulin recommendations. The technical feasibility of the proposed safety system was evaluated in a pilot study including eight adult subjects with type 1 diabetes on multiple daily injections over a duration of six weeks. Glycemic control and safety system functioning were compared between the two-weeks run-in period and the end point at eight weeks. A standard insulin bolus calculator was employed to recommend insulin doses. RESULTS: Overall, glycemic control improved over the evaluated period. In particular, percentage time in the hypoglycemia range (<3.0 mmol/l) significantly decreased from 0.82% (0.05-4.79) at run-in to 0.33% (0.00-0.93) at endpoint ( P = .02). This was associated with a significant increase in percentage time in target range (3.9-10.0 mmol/l) from 52.8% (38.3-61.5) to 61.3% (47.5-71.7) ( P = .03). There was also a reduction in number of carbohydrate recommendations. CONCLUSION: A safety system for an insulin dose recommender has been proven to be a viable solution to reduce the number of adverse events associated to glucose control in type 1 diabetes, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prediction of glucose level conditions from sequential data

  • Mordvanyuk, Natalia
  • Torrent-Fontbona, Ferran
  • López Ibáñez, Beatriz
In type 1 diabetes management, mobile health applications are becoming a cornerstone to empower people to self-manage their disease. There are many applications addressed to calculate insulin doses based on the current information (e.g. carbohydrates intake) and a few of them are accompanied by modules able to supervise postprandial conditions and recommend corrective actions if the user falls in an abnormal state (i.e. hyperglycaemia or hypoglycaemia). On the other hand, mobile apps favour the gathering of historical data from which machine learning techniques can be used to predict if user conditions will worsen. This work presents the application of k-nearest neighbour on the historical data gathered on patients, so that given the information related to a sequence of meals, the method is able to predict if the patient will fall in an abnormal condition. The experimentation has been carried out with the UVA-Padova type 1 diabetes simulator over eleven adult profiles. Results corroborate that the use of sequential data improve significantly the prediction outcome when forecasts distinguish the type of meal (breakfast, lunch and dinner), This work has received funding from the EU Horizon 2020 research and innovation programme under grant agreement No 689810 (PEPPER), and from the University of Girona under the grant MPCUdG2016 (Ajut per a la millora de la productivitat científica dels grups de recerca), and the Spanish MINECO under the grant number DPI2013- 47450-C21-R. This work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 2014-2016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Safety and Feasibility of the PEPPER Adaptive Bolus Advisor and Safety System: A Randomized Control Study

  • Avari, Parizad
  • Leal Moncada, Yenny Teresa
  • Herrero i Viñas, Pau
  • Wos, Marzena
  • Jugnee, Narvada
  • Arnoriaga Rodríguez, María
  • Thomas, Maria
  • Liu, Chengyuan
  • Massana i Raurich, Joaquim
  • López Ibáñez, Beatriz
  • Lucian, Nita
  • Martin, Clare
  • Fernández-Real Lemos, José Manuel
  • Oliver, Nick
  • Fernández-Balsells, Mercè
  • Reddy, Monika
Background: The Patient Empowerment through Predictive Personalized Decision Support (PEPPER) system provides personalized bolus advice for people with type 1 diabetes. The system incorporates an adaptive insulin recommender system (based on case-based reasoning, an artificial intelligence methodology), coupled with a safety system, which includes predictive glucose alerts and alarms, predictive low-glucose suspend, personalized carbohydrate recommendations, and dynamic bolus insulin constraint. We evaluated the safety and efficacy of the PEPPER system compared to a standard bolus calculator. Methods: This was an open-labeled multicenter randomized controlled crossover study. Following 4-week run-in, participants were randomized to PEPPER/Control or Control/PEPPER in a 1:1 ratio for 12 weeks. Participants then crossed over after a washout period. The primary end-point was percentage time in range (TIR, 3.9-10.0 mmol/L [70-180 mg/dL]). Secondary outcomes included glycemic variability, quality of life, and outcomes on the safety system and insulin recommender. Results: Fifty-four participants on multiple daily injections (MDI) or insulin pump completed the run-in period, making up the intention-to-treat analysis. Median (interquartile range) age was 41.5 (32.3-49.8) years, diabetes duration 21.0 (11.5-26.0) years, and HbA1c 61.0 (58.0-66.1) mmol/mol. No significant difference was observed for percentage TIR between the PEPPER and Control groups (62.5 [52.1-67.8] % vs. 58.4 [49.6-64.3] %, respectively, P = 0.27). For quality of life, participants reported higher perceived hypoglycemia with the PEPPER system despite no objective difference in time spent in hypoglycemia. Conclusions: The PEPPER system was safe, but did not change glycemic outcomes, compared to control. There is wide scope for integrating PEPPER into routine diabetes management for pump and MDI users. Further studies are required to confirm overall effectiveness. Clinical trial registration: ClinicalTrials.gov NCT03849755, The work outlined in this manuscript was developed with the support of the awarded distinction by the Generalitat de Catalunya 2017 SGR 1551, and the European Union’s Horizon 2020 research and innovation programme under grant agreement No 689810 (PEPPER)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Handling Missing Phenotype Data with Random Forests for Diabetes Risk Prognosis

  • López Ibáñez, Beatriz
  • Viñas, Ramon
  • Torrent-Fontbona, Ferran
  • Fernández-Real Lemos, José Manuel
Comunicació de congrés presentada a: Workshop on Artificial Intelligence for Diabetes (AID) (1st: 2016: The Hague, Holanda) i European Conference on Artificial Intelligence (ECAI) (22nd: The Hage, Holanda), Aquest workshop ha rebut finançament del programa d'investigació i innovació EU Horizon 2020 sota el núm. d'ajut 689810, Machine learning techniques are the cornerstone to handle the amounts of information available for building comprehensive models for decision support in medical practice. However, the datasets use to have a lot of missing information. In this work we analyse how the random forests technique could be used for dealing with missing phenotype values in order to prognosticate diabetes type 2, This project has received funding from the grant of the University of Girona 2016-2018 (MPCUdG2016) and the European Unions Horizon 2020 research and innovation programme under grant agreement No 689810 (PEPPER). The work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 2014-2016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Application of Usability Engineering to the Development of a Personalised Decision Support System for Type 1 Diabetes Self-Management [Pòster]

  • Martin, Clare
  • Aldea, Arantza
  • Alshaigy, B.
  • Avari, Parizad
  • Duce, David
  • Fernández-Balsells, Mercè
  • Fernández-Real Lemos, José Manuel
  • Harrison, R.
  • Herrero i Viñas, Pau
  • Jugnee, Narvada
  • Lui, C.
  • López Ibáñez, Beatriz
  • Massana i Raurich, Joaquim
  • Leal Moncada, Yenny Teresa
  • Russell, A.
  • Reddy, Monika
  • Waite, Marion
  • Wos, Marzena
  • Oliver, Nick
Pòster de congrés presentat a: International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (12th: 20-23 Febrer 2019: Berlin), PEPPER (Patient Empowerment through Predictive PERsonalised decision support) is an EU-funded research project which aims to improve the self-management behaviour of adults with type 1 diabetes (T1D). Human factors and ergonomics play a key role in the development of this system, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Estudio de factibilidad del sistema de seguridad pepper, un componente de un sistema personalizado de soporte de decisiones de autogestión de la DM1

  • Leal Moncada, Yenny Teresa
  • Wos, Marzena
  • Avari, Parizad
  • Herrero i Viñas, Pau
  • Esteve, Eduardo
  • Sojo-Vega, Lidia
  • Fernández-Balsells, Mercè
Presentació de la comunicació de congrés presentada al Congreso Nacional de la Sociedad Española de Diabetes (24-26 d'abril: Sevilla), Background: The Patient Empowerment through Predictive Personalised Decision Support (PEPPER) integrated system is designed to provide personalised bolus advice for people with Type 1 diabetes (T1DM). The system delivers insulin dosing decision support based on case-based reasoning (CBR), coupled with a safety system, which includes predictive glucose alarms, low glucose suspend for insulin pump users, and personalised carbohydrate recommendations. We aimed to assess proof of concept and feasibility of the PEPPER safety system. Methods: This is a Phase 1 non-randomised open-labelled 8-week study to assess the safety system outcomes (without CBR-based insulin dosing decision support). Eight adults with T1DM on multiple daily injection of insulin (MDI) participated. Following two weeks of unblinded continuous glucose monitoring (CGM, Dexcom G5), participants completed six further weeks using CGM with the PEPPER safety system active. Baseline outcomes derived from the run-in period were compared with end-point. Results: Participants were (median (interquartile range)) aged 38(31.8-53.5) years, with a diabetes duration of 22.5(18.0-26.5) years and HbA1c 63(57-66) mmol/mol. Percentage time in hypoglycaemia (<3.0mmol/l) significantly decreased from 0.82% at run-in to 0.33% at endpoint (p=0.02), with a significant increase in percentage time in target (3.9-10.0mmol/l; p=0.027). The total number of alarms to carers significantly decreased (p=0.005). There was also a reduction in number of carbohydrate recommendations. Conclusions: The PEPPER safety system is safe and feasible to use as a component of the overall system and to integrate with the PEPPER adaptive bolus calculator. The data suggest that the PEPPER safety system has the potential to enable improvements in hypoglycaemia and percentage time in range., Objetivos: El sistema inteligente de soporte de decisiones para la autogestión de la diabetes tipo 1 (DM1) Patient Empowerment through Predictive Personalised Decision Support (PEPPER) está diseñado para empoderar a las personas con DM1 proporcionándoles recomendaciones de bolo personalizadas y adaptativas. El sistema asiste al paciente en la toma de decisiones sobre dosificación de bolos, a través de un sistema de razonamiento basado en casos (CBR), junto con un sistema de seguridad. Este último incluye alarmas de glucosa predictivas, suspensión de insulina al predecir hipoglucemias para usuarios de bombas de insulina, restricciones dinámicas de seguridad en la insulina y recomendaciones personalizadas de carbohidratos. El objetivo fue evaluar la prueba de concepto y la viabilidad del sistema de seguridad PEPPER. Material y Métodos: Se describen los resultados de la primera fase de un estudio de 8 semanas de brazo abierto y no-aleatorizado para evaluar los resultados del sistema de seguridad (sin utilizar el CBR). Participaron ocho adultos con DM1 utilizando terapia con múltiples dosis diarias de insulina (MDI), reclutados en el Imperial College (Londres, Reino Unido) y en el Hospital Dr. Josep Trueta (Girona, España). Inicialmente, los participantes completaron un período de adaptación de dos semanas utilizando un monitor continuo de glucosa (CGM, Dexcom G5™), un monitor de actividad Mi Band 1s, el Accu-Check® Aviva Connect para calibrar el CGM y un Smartphone donde se ejecutaba una calculadora de bolo estándar y la aplicación PEPPER Mobile Application. Luego, los participantes completaron otras seis semanas utilizando los componentes del PEPPER con el sistema de seguridad activo y el CBR inactivo. Los resultados derivados del período de adaptación se compararon con los obtenidos al final del uso del sistema de seguridad. Resultados: Los participantes (mediana (rango intercuartílico)) tenían 38 años (31.8-53.5) años, con una DM1 de 22.5 (18.0-26.5) años y HbA1c 7.9 (7.4-8.2)%. El porcentaje de tiempo en hipoglucemia (<54 mg/dL) disminuyó significativamente de 0.82 (0.05-4.79)% en el inicio al 0.33 (0.00-0.93)% al finalizar el uso del sistema de seguridad (p=0.02), con un aumento significativo en el porcentaje de tiempo en objetivo (70-180 mg/dL) de 52.8 (38.3-61.5)% a 61.3 (47.5-71.7)% (p = 0.03). El número total de alarmas de hipoglucemia para los cuidadores disminuyó significativamente de 5.50 (4.00-9.50) a 2.50 (1.75-5.25). También hubo una reducción en el número de recomendaciones de ingesta de carbohidratos. Conclusiones: En general, el control glucémico mejoró durante el período evaluado. Los datos sugieren que el sistema de seguridad PEPPER tiene el potencial de permitir mejoras en hipoglucemia y en el porcentaje de tiempo en objetivo de control glucémico. Este sistema de seguridad es seguro y factible de usar como un componente del sistema global PEPPER y puede integrarse con la calculadora de bolo adaptativa basada en CBR, This project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement No 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Prediction of glucose level conditions from sequential data [Pòster]

  • Mordvanyuk, Natalia
  • Torrent-Fontbona, Ferran
  • López Ibáñez, Beatriz
Pòster de congrés presentat a: 20th International Conference of the Catalan Association for Artificial Intelligence, CCIA, October 25-27 th, Deltebre, 2017, Pòster relacionat amb la comunicació presentada al '20th International Conference of the Catalan Association for Artificial Intelligence' i publicada a 'Frontiers in Artificial Intelligence and Applications', 2017, vol. 300, p. 227-232. DOI: https://doi.org/10.3233/978-1-61499-806-8-227, In type 1 diabetes management, mobile health applications are becoming a cornerstone to empower people to self-manage their disease. There are many applications addressed to calculate insulin doses based on the current information (e.g. carbohydrates intake) and a few of them are accompanied by modules able to supervise postprandial conditions and recommend corrective actions if the user falls in an abnormal state (i.e. hyperglycaemia or hypoglycaemia). On the other hand, mobile apps favour the gathering of historical data from which machine learning techniques can be used to predict if user conditions will worsen. This work presents the application of k-nearest neighbour on the historical data gathered on patients, so that given the information related to a sequence of meals, the method is able to predict if the patient will fall in an abnormal condition. The experimentation has been carried out with the UVA-Padova type 1 diabetes simulator over eleven adult profiles. Results corroborate that the use of sequential data improve significantly the prediction outcome when forecasts distinguish the type of meal (breakfast, lunch and dinner)., This work has received funding from the EU Horizon2020 research and innovation programme under grant agreement No689810 (PEPPER), and from the University of Girona under the grant MPCUdG2016 (Ajut per a la millora de la productivitat científica dels grups de recerca), and the Spanish MINECO under the grant number DPI2013-47450-C21-R. This work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 2014-2016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Involving physical activity in insulin recommender systems with the use of wearables

  • López Ibáñez, Beatriz
  • Pozo-Alonso, Alejandro
  • Torrent-Fontbona, Ferran
Comunicació de congrés presentada a: Informatics for health conference (2017: Manchester, UK). Informatics for Health 2017: 24-26 April 2017: Manchester, UK (Paper session: Diabetes ans ageing. Exchange 3. 26 April 2017), Aquest workshop ha rebut finançament del programa d'investigació i innovació EU Horizon 2020 sota el núm. d'ajut 689810, Type Diabetes Mellitus 1 (TDM1 patients are able to determine the amount of insulin to be injected in a dose according to the most recent food ingest and other factors such as physical activity, or menstruation. Recently, other elements such as stress, have been determined as key factors too, which influence this decision. Dealing with all these factors is a complex task, and patients suffering this illness are very active in looking for tools that can help them in these daily decisions. In that regard, insulin recommender systems are decision support system (DSS) designed with the aim of providing the appropriate insulin dose to a given patient in a given moment. Moreover, the deployment of such kind of DSS in mobile devices is offering the opportunity to use new sensors that may provide additional information to improve the recommendations. For example, some researchers are exploring mobile cameras to process the food ingested in order to automatically count the carbohydrates to be considered. Other sensors, like smartwatches or wrist bands offer the opportunity to track patients’ physical activity or even their stress level in order to feed the next insulin recommendation decision with this information. Our work concerns the development of an adaptive recommender system that exploits the information from wearables, in order to improve the recommendation provided to TDM1 patients, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Feasibility of Safety System within a Novel Personalised Decision Support Tool: The Patient Empowerment Through Predictive Personalised Decision Support (PEPPER) Study

  • Avari, Parizad
  • Leal Moncada, Yenny Teresa
  • Wos, Marzena
  • Sivasithamparam, Kumuthine
  • Liu, Chengyuan
  • Herrero i Viñas, Pau
  • Jugnee, Narvada
  • Thomas, Maria
  • Martin, Clare
  • Reddy, Monika
  • Fernández-Real Lemos, José Manuel
  • Oliver, Nick
  • Fernández-Balsells, Mercè
Presentació de la comunicació de congrés presentada a: International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)(12th: febrer 2019: Berlin), Background: The Patient Empowerment through Predictive Personalised Decision Support (PEPPER) integrated system is designed to provide personalised bolus advice for people with Type 1 diabetes (T1DM). The system delivers insulin dosing decision support based on case-based reasoning (CBR), coupled with a safety system, which includes predictive glucose alarms, low glucose suspend for insulin pump users, and personalised carbohydrate recommendations. We aimed to assess proof of concept and feasibility of the PEPPER safety system. Methods: This is a Phase 1 non-randomised open-labelled 8-week study to assess the safety system outcomes (without CBR-based insulin dosing decision support). Eight adults with T1DM on multiple daily injection of insulin (MDI) participated. Following two weeks of unblinded continuous glucose monitoring (CGM, Dexcom G5), participants completed six further weeks using CGM with the PEPPER safety system active. Baseline outcomes derived from the run-in period were compared with end-point. Results: Participants were (median (interquartile range)) aged 38(31.8-53.5) years, with a diabetes duration of 22.5(18.0-26.5) years and HbA1c 63(57-66) mmol/mol. Percentage time in hypoglycaemia (<3.0mmol/l) significantly decreased from 0.82% at run-in to 0.33% at endpoint (p=0.02), with a significant increase in percentage time in target (3.9-10.0mmol/l; p=0.027). The total number of alarms to carers significantly decreased (p=0.005). There was also a reduction in number of carbohydrate recommendations. Conclusions: The PEPPER safety system is safe and feasible to use as a component of the overall system and to integrate with the PEPPER adaptive bolus calculator. The data suggest that the PEPPER safety system has the potential to enable improvements in hypoglycaemia and percentage time in range, Objetivos: El sistema inteligente de soporte de decisiones para la autogestión de la diabetes tipo 1 (DM1) Patient Empowerment through Predictive Personalised Decision Support (PEPPER) está diseñado para empoderar a las personas con DM1 proporcionándoles recomendaciones de bolo personalizadas y adaptativas. El sistema asiste al paciente en la toma de decisiones sobre dosificación de bolos, a través de un sistema de razonamiento basado en casos (CBR), junto con un sistema de seguridad. Este último incluye alarmas de glucosa predictivas, suspensión de insulina al predecir hipoglucemias para usuarios de bombas de insulina, restricciones dinámicas de seguridad en la insulina y recomendaciones personalizadas de carbohidratos. El objetivo fue evaluar la prueba de concepto y la viabilidad del sistema de seguridad PEPPER. Material y Métodos: Se describen los resultados de la primera fase de un estudio de 8 semanas de brazo abierto y no-aleatorizado para evaluar los resultados del sistema de seguridad (sin utilizar el CBR). Participaron ocho adultos con DM1 utilizando terapia con múltiples dosis diarias de insulina (MDI), reclutados en el Imperial College (Londres, Reino Unido) y en el Hospital Dr. Josep Trueta (Girona, España). Inicialmente, los participantes completaron un período de adaptación de dos semanas utilizando un monitor continuo de glucosa (CGM, Dexcom G5™), un monitor de actividad Mi Band 1s, el Accu-Check® Aviva Connect para calibrar el CGM y un Smartphone donde se ejecutaba una calculadora de bolo estándar y la aplicación PEPPER Mobile Application. Luego, los participantes completaron otras seis semanas utilizando los componentes del PEPPER con el sistema de seguridad activo y el CBR inactivo. Los resultados derivados del período de adaptación se compararon con los obtenidos al final del uso del sistema de seguridad. Resultados: Los participantes (mediana (rango intercuartílico)) tenían 38 años (31.8-53.5) años, con una DM1 de 22.5 (18.0-26.5) años y HbA1c 7.9 (7.4-8.2)%. El porcentaje de tiempo en hipoglucemia (<54 mg/dL) disminuyó significativamente de 0.82 (0.05-4.79)% en el inicio al 0.33 (0.00-0.93)% al finalizar el uso del sistema de seguridad (p=0.02), con un aumento significativo en el porcentaje de tiempo en objetivo (70-180 mg/dL) de 52.8 (38.3-61.5)% a 61.3 (47.5-71.7)% (p = 0.03). El número total de alarmas de hipoglucemia para los cuidadores disminuyó significativamente de 5.50 (4.00-9.50) a 2.50 (1.75-5.25). También hubo una reducción en el número de recomendaciones de ingesta de carbohidratos. Conclusiones: En general, el control glucémico mejoró durante el período evaluado. Los datos sugieren que el sistema de seguridad PEPPER tiene el potencial de permitir mejoras en hipoglucemia y en el porcentaje de tiempo en objetivo de control glucémico. Este sistema de seguridad es seguro y factible de usar como un componente del sistema global PEPPER y puede integrarse con la calculadora de bolo adaptativa basada en CBR, Project Funding: European Union's Horizon 2020 (Grant No 689810)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Evaluación de un sistema personalizado de soporte de decisiones de autogestión de la DM1 [Pòster]

  • Wos, Marzena
  • Leal Moncada, Yenny Teresa
  • Fernández-Balsells, Mercè
  • Martin, Clare
  • Ricart, Wilfredo
  • Sojo-Vega, Lidia
  • Fernández-Real Lemos, José Manuel
Pòster de congrés presentat a: Congreso Nacional de la Sociedad Española de Diabetes (SED) (28è: 5-7 Abril 2017: Barcelona), Patient Empowerment Through Predictive Personalised Decision Support (PEPPER) es un projecto de investigación que desarrolla un sistema personalizado de soporte de decisiones para la autogestión de la diabetes tipo 1 (DM1). PEPPER proporciona recomendaciones en cuanto a la dosis de bolo de insulina (utilizando el razonamiento basado en casos (CBR), una técnica de inteligencia artificial que se adapta a nuevas situaciones de acuerdo con las experiencias pasadas) e ingesta de carbohidratos, basándose en un modelo informático predictivo que promueve la seguridad, proporcionando además, alarmas de predicción de glucemia, suspensión de infusión de insulina y detección de fallos. El objetivo de este proyecto es evaluar la factibilidad, la seguridad, la usabilidad y la viabilidad del sistema PEPPER, Este proyecto ha recibido financiación del programa de investigación e innovación Horizonte 2020 de la UE bajo acuerdo de subvención nº 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Editorial. Special section on artificial intelligence for diabetes

  • López Ibáñez, Beatriz
  • Martin, Clare
  • Herrero i Viñas, Pau
This special section of this issue of the Artificial Intelligence in Medicine (AIIM) journal originates from the First Workshop on Artificial intelligence for Diabetes (AID 2016) on 30th August 2016. The workshop was part of the 22nd European Conference on Artificial Intelligence (ECAI 2016) in The Hague, Holland. Authors with papers accepted for the workshop were subsequently invited to revise and extend their work for publication in this issue, and a wider call was also announced to attract work from other outstanding researchers in the area. Authors were invited to submit original contributions on the overarching theme of Artificial Intelligence-based solutions to problems associated with diabetes. In particular, papers were sought on topics including Intelligent solutions to empower citizens with self-management of health conditions; Intelligent systems for glucose prediction and alarm generation; clinical decision support tools to deal with the avalanche of data gathered by sensors; data mining approaches for risk prediction and prevention of diabetes comorbidities; as well as community tools, platforms to support research in this area and data sets for benchmarkin, The workshop was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 689810 (PEPPER)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Long-Term Glucose Forecasting Using a Physiological Model and Deconvolution of the Continuous Glucose Monitoring Signal

  • Liu, Chengyuan
  • Vehí, Josep
  • Avari, Parizad
  • Reddy, Monika
  • Oliver, Nick
  • Georgiou, Pantelis
  • Herrero i Viñas, Pau
Blood glucose forecasting in type 1 diabetes (T1D) management is a maturing field with numerous algorithms being published and a few of them having reached the commercialisation stage. However, accurate long-term glucose predictions (e.g., >60 min), which are usually needed in applications such as precision insulin dosing (e.g., an artificial pancreas), still remain a challenge. In this paper, we present a novel glucose forecasting algorithm that is well-suited for long-term prediction horizons. The proposed algorithm is currently being used as the core component of a modular safety system for an insulin dose recommender developed within the EU-funded PEPPER (Patient Empowerment through Predictive PERsonalised decision support) project. (2) Methods: The proposed blood glucose forecasting algorithm is based on a compartmental composite model of glucose–insulin dynamics, which uses a deconvolution technique applied to the continuous glucose monitoring (CGM) signal for state estimation. In addition to commonly employed inputs by glucose forecasting methods (i.e., CGM data, insulin, carbohydrates), the proposed algorithm allows the optional input of meal absorption information to enhance prediction accuracy. Clinical data corresponding to 10 adult subjects with T1D were used for evaluation purposes. In addition, in silico data obtained with a modified version of the UVa-Padova simulator was used to further evaluate the impact of accounting for meal absorption information on prediction accuracy. Finally, a comparison with two well-established glucose forecasting algorithms, the autoregressive exogenous (ARX) model and the latent variable-based statistical (LVX) model, was carried out. (3) Results: For prediction horizons beyond 60 min, the performance of the proposed physiological model-based (PM) algorithm is superior to that of the LVX and ARX algorithms. When comparing the performance of PM against the secondly ranked method (ARX) on a 120 min prediction horizon, the percentage improvement on prediction accuracy measured with the root mean square error, A-region of error grid analysis (EGA), and hypoglycaemia prediction calculated by the Matthews correlation coefficient, was 18.8%, 17.9%, and 80.9%, respectively. Although showing a trend towards improvement, the addition of meal absorption information did not provide clinically significant improvements. (4) Conclusion: The proposed glucose forecasting algorithm is potentially well-suited for T1D management applications which require long-term glucose predictions, This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 689810, and by the Spanish Ministry of Science and Innovation under Grant DPI2016-78831-C2-2-R
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Efficacy and safety of the Patient Empowerment through Predictive Personalised Decision Support (PEPPER) system: an open-label randomised controlled trial [Pòster]

  • Avari, Parizad
  • Leal Moncada, Yenny Teresa
  • Wos, Marzena
  • Jugnee, Narvada
  • Thomas, Maria
  • Massana i Raurich, Joaquim
  • López Ibáñez, Beatriz
  • Nita, Lucian
  • Martin, Clare
  • Herrero i Viñas, Pau
  • Oliver, Nick
  • Fernández-Real Lemos, José Manuel
  • Reddy, Monika
  • Fernández-Balsells, Mercè
Pòster de congrés presentat a: ATTD 2020 - 13th International Conference on Advanced Technologies & Treatments for Diabetes”, celebrat a Madrid del 19 al 22 de febrer de 2020, PEPPER (Patient Empowerment through Predictive PERsonalised decision support) is an EU-funded H2020 project that provides personalised insulin bolus advice for people with Type 1 diabetes (T1D). Here, we evaluate the safety, feasibility and usability of the PEPPER system compared to a standard bolus calculator, This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

PEPPER: Patient Empowerment Through Predictive Personalised Decision Support

  • Herrero i Viñas, Pau
  • López Ibáñez, Beatriz
  • Martin, Clare
Comunicació de congrés presentada a: Workshop on Artificial Intelligence for Diabetes (AID) (1st: 2016: The Hague, Holanda) i European Conference on Artificial Intelligence (ECAI) (22nd: The Hage, Holanda), Aquest workshop ha rebut finançament del programa d'investigació i innovació EU Horizon 2020 sota el núm. d'ajut 689810, PEPPER is a newly-launched three-year research project, funded by the EU Horizon 2020 Framework. It will create a portable personalised decision support system to empower individuals on insulin therapy to self-manage their condition. PEPPER employs Case-Based Reasoning to advise about insulin bolus doses, drawing on various sources of physiological, lifestyle, environmental and social data. It also uses a Model-Based Reasoning approach to maximise users’ safety. The system will be integrated with an unobtrusive insulin patch pump and has a patient-centric development approach in order to improve patient self-efficacy and adherence to treatment, This project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement No 689810
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

eXiT Research Group at the University of Girona: Artificial Intelligence and Machine Learning Applied to Medicine and Healthcare

  • López Ibáñez, Beatriz
  • Mordvanyuk, Natalia
  • Massana i Raurich, Joaquim
  • Torrent-Fontbona, Ferran
  • Cáceres Bartrolí, Gerard
  • Pous i Sabadí, Carles
Comunicació presentada al I Workshop de Grupos de Investigación Españoles de IA en Biomedicina (IABiomed 2018) : XVIII Conferencia de la Asociación Española para la Inteligencia Artificial (CAEPIA 2018) : Granada, 23-26 de octubre de 2018, This paper describes the research activity of the eXiT research group at the Universitat of Girona and the main results achieved. The research is organized in four main groups: prognosis, clinical decision support systems, mHealth, and biosignal processing. The paper describes past, current and future research of the group, This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 689810 (PEPPER). Work developed with the support of the awarded distinction by the Generalitat de Catalunya 2017 SGR 1551, the MESC project funded by the Spanish MINECO (Ref. DPI2013-47450-C21-R), and the University of Girona grant to supporting research groups to improve their scientific productivity (MPCUdG2016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Prediction of hyperglycaemia and hypoglycaemia events using longitudinal data [Pòster]

  • Mordvanyuk, Natalia
  • Torrent-Fontbona, Ferran
  • López Ibáñez, Beatriz
Pòster de congrés presentat a: 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2018): 14-17 February, 2018, Vienna, Austria, In type 1 diabetes management, mobile health applications are becoming a cornerstone to empower people to self-manage their disease. There are many applications addressed to calculate insulin doses based on the current information (e.g. carbohydrates intake) and a few of them are accompanied by modules able to supervise postprandial conditions and recommend corrective actions if the user falls in an abnormal state (i.e. hyperglycaemia or hypoglycaemia). On the other hand, mobile apps favour the gathering of historical data from which machine learning techniquescanbeusedtopredictifuserconditionswillworsen. Thisworkpresentstheapplicationofk-nearestneighbouronthehistoricaldatagatheredonpatients,sothatgiven the information related to a sequence of meals, the method is able to predict if the patient will fall in an abnormal condition. The experimentation has been carried out with the UVA-Padova type 1 diabetes simulator over eleven adult profiles. Results corroborate that the use of sequential data improve significantly the prediction outcome when forecastsdistinguishthetypeofmeal(breakfast,lunchanddinner), This work has received funding from the EU Horizon2020 research and innovation programme under grant agreement No689810 (PEPPER), and from the University of Girona under the grant MPCUdG2016 (Ajut per a la millora de la productivitat científica dels grups de recerca), and the Spanish MINECO under the grant number DPI2013-47450-C21-R. This work has been developed with the support of the research group SITES awarded with distinction by the Generalitat de Catalunya (SGR 2014-2016)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Single Nucleotide Polymorphism relevance learning with Random Forests for Type 2 diabetes risk prediction Type 2 diabetes Random Forest Feature learning Predictive model Gini importance

  • López Ibáñez, Beatriz
  • Torrent-Fontbona, Ferran
  • Viñas, Ramon
  • Fernández-Real Lemos, José Manuel
The use of artificial intelligence techniques to find out which Single Nucleotide Polymorphisms (SNPs) promote the development of a disease is one of the features of medical research, as such techniques may potentially aid early diagnosis and help in the prescription of preventive measures. In particular, the aim is to help physicians to identify the relevant SNPs related to Type 2 diabetes, and to build a decision-support tool for risk prediction. Methods: We use the Random Forest (RF) technique in order to search for the most important attributes (SNPs) related to diabetes, giving a weight (degree of importance), ranging between 0 and 1, to each attribute. Support Vector Machines and Logistic Regression have also been used since they are two other machine learning techniques that are well-established in the health community. Their performance has been compared to that achieved by RF. Furthermore, the relevance of the attributes obtained through the use of RF has then been used to perform predictions with k-Nearest Neighbour method weighting attributes in the similarity measure according to the relevance of the attributes with RF. Results: Testing is performed on a set of 677 subjects. RF is able to handle the complexity of features' interactions, overfitting, and unknown attribute values, providing the SNPs' relevance with an up to 0.89 area under the ROC curve in terms of risk prediction. RF outperforms all the other tested machine learning techniques in terms of prediction accuracy, and in terms of the stability of the estimated relevance of the attributes. Conclusions: The Random Forest is a useful method for learning predictive models and the relevance of SNPs without any underlying assumption, This work was supported by the European Unions Horizon 2020 research and innovation programme [grant number 689810, PEPPER]; the University of Girona [grant number MPCUdG2016]; and the Spanish MINECO [grant number DPI2013-47450-C21-R].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

The PEPPER System Application Program Interface [Pòster]

  • Herrero i Viñas, Pau
  • Massana i Raurich, Joaquim
  • Leal Moncada, Yenny Teresa
  • Nita, Lucian
  • Avari, Parizad
  • Duce, David
  • Aldea, Arantza
  • Georgiou, Pantelis
  • Fernández-Real Lemos, José Manuel
  • Fernández-Balsells, Mercè
  • Oliver, Nick
  • López Ibáñez, Beatriz
  • Martin, Clare
Pòster de congrés presentat a: ATTD 2020 - 13th International Conference on Advanced Technologies & Treatments for Diabetes”, celebrat a Madrid del 19 al 22 de febrer de 2020, PEPPER (Patient Empowerment through Predictive PERsonalised decision support) is an EU-funded H2020 project that provides a personalized decision support system for type 1 diabetes selfmanagement. This work describes the application program interface (API) developed for this purpose, This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 689810